The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 8, Issue 12, 2014, Pages 1661-1667

  Nguyen, Geoffrey C ^a,b   Elnahas, Ahmad ^c   Jackson, Timothy D ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Corticosteroids; Crohn's disease; Inflammatory bowel disease; Postoperative complications; Surgery; Ulcerative colitis

Indexed keywords

GLUCOCORTICOID;

ADULT; FACTUAL DATABASE; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; REOPERATION; SEPSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES; VENOUS THROMBOEMBOLISM;

ADULT; DATABASES, FACTUAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; REOPERATION; SEPSIS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 84918799252     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.07.007     Document Type: Article

References (39)

1. Nguyen G.C., Nugent Z., Shaw S., Bernstein C.N. Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. Gastroenterology 2011, 141:90-97.
2. Targownik L.E., Singh H., Nugent Z., Bernstein C.N. The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort. Am J Gastroenterol 2012, 107:1228-1235.
3. Herrinton L.J., Liu L., Fireman B., Lewis J.D., Allison J.E., Flowers N., et al. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology 2009, 137:502-511.
4. Fasth S., Hellberg R., Hulten L., Magnusson O. Early complications after surgical treatment for Crohn's disease with particular reference to factors affecting their development. Acta Chir Scand 1980, 146:519-526.
5. Heimann T.M., Greenstein A.J., Mechanic L., Aufses A.H. Early complications following surgical treatment for Crohn's disease. Ann Surg 1985, 201:494-498.
6. Post S., Betzler M., von Ditfurth B., Schurmann G., Kuppers P., Herfarth C. Risks of intestinal anastomoses in Crohn's disease. Ann Surg 1991, 213:37-42.
7. Ziv Y., Church J.M., Fazio V.W., King T.M., Lavery I.C. Effect of systemic steroids on ileal pouch-anal anastomosis in patients with ulcerative colitis. Dis Colon Rectum 1996, 39:504-508.
8. Page M.J., Poritz L.S., Kunselman S.J., Koltun W.A. Factors affecting surgical risk in elderly patients with inflammatory bowel disease. J Gastrointest Surg 2002, 6:606-613.
9. Mahadevan U., Loftus E.V., Tremaine W.J., Pemberton J.H., Harmsen W.S., Schleck C.D., et al. Azathioprine or 6-mercaptopurine before colectomy for ulcerative colitis is not associated with increased postoperative complications. Inflamm Bowel Dis 2002, 8:311-316.
10. Aberra F.N., Lewis J.D., Hass D., Rombeau J.L., Osborne B., Lichtenstein G.R. Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. Gastroenterology 2003, 125:320-327.
11. Tay G.S., Binion D.G., Eastwood D., Otterson M.F. Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty. Surgery 2003, 134:565-572.
12. Bruewer M., Utech M., Rijcken E.J., Anthoni C., Laukoetter M.G., Kersting S., et al. Preoperative steroid administration: effect on morbidity among patients undergoing intestinal bowel resection for Crohn's disease. World J Surg 2003, 27:1306-1310.
13. Colombel J.F., Loftus E.V., Tremaine W.J., Pemberton J.H., Wolff B.G., Young-Fadok T., et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004, 99:878-883.
14. Subramanian V., Saxena S., Kang J.Y., Pollok R.C. Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 2008, 103:2373-2381.
15. Khuri S.F., Henderson W.G., Daley J., Jonasson O., Jones R.S., Campbell D.A., et al. The patient safety in surgery study: background, study design, and patient populations. J Am Coll Surg 2007, 204:1089-1102.
16. Daley J., Khuri S.F., Henderson W., Hur K., Gibbs J.O., Barbour G., et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997, 185:328-340.
17. Khuri S.F., Daley J., Henderson W., Hur K., Gibbs J.O., Barbour G., et al. Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997, 185:315-327.
18. Daley J., Forbes M.G., Young G.J., Charns M.P., Gibbs J.O., Hur K., et al. Validating risk-adjusted surgical outcomes: site visit assessment of process and structure. National VA Surgical Risk Study. J Am Coll Surg 1997, 185:341-351.
19. Khuri S.F., Henderson W.G., Daley J., Jonasson O., Jones R.S., Campbell D.A., et al. Successful implementation of the Department of Veterans Affairs' National Surgical Quality Improvement Program in the private sector: the Patient Safety in Surgery study. Ann Surg 2008, 248:329-336.
20. Lichtenstein G.R., Feagan B.G., Cohen R.D., Salzberg B.A., Diamond R.H., Chen D.M., et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006, 4:621-630.
21. Lichtenstein G.R., Feagan B.G., Cohen R.D., Salzberg B.A., Diamond R.H., Price S., et al. Serious infection and mortality in patients with Crohn's disease: more than 5years of follow-up in the TREAT registry. Am J Gastroenterol 2012, 107:1409-1422.
22. Ferrante M., D'Hoore A., Vermeire S., Declerck S., Noman M., Van Assche G., Hoffman I., Rutgeerts P., Penninckx F. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009, 15:1062-1070.
23. Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010, 375:657-663.
24. Johannesdottir S.A., Horvath-Puho E., Dekkers O.M., Cannegieter S.C., Jorgensen J.O., Ehrenstein V., et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Int. Med. 2013, 173:743-752.
25. Gould M.K., Garcia D.A., Wren S.M., Karanicolas P.J., Arcelus J.I., Heit J.A., et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141:e227S-e277S.
26. Yang Z., Wu Q., Wang F., Wu K., Fan D. Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery. Aliment Pharmacol Ther 2012, 36:922-928.
27. Lau C., Dubinsky M., Melmed G., Vasiliauskas E., Berel D., McGovern D., et al. The impact of preoperative serum anti-TNFalpha therapy levels on early postoperative outcomes in inflammatory bowel disease surgery. Ann Surg 2014, [EPub 2014 Jun 19].
28. Narula N., Charleton D., Marshall J.K. Meta-analysis: peri-operative anti-TNFalpha treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2013, 37:1057-1064.
29. Waterman M., Xu W., Dinani A., Steinhart A.H., Croitoru K., Nguyen G.C., et al. Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease. Gut 2013, 62:387-394.
30. Norgard B.M., Nielsen J., Qvist N., Gradel K.O., de Muckadell O.B., Kjeldsen J. Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study. Aliment Pharmacol Ther 2012, 35:1301-1309.
31. Rosenfeld G., Qian H., Bressler B. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis. J Crohns Colitis 2013, 7:868-877.
32. Uchino M., Ikeuchi H., Matsuoka H., Bando T., Ichiki K., Nakajima K., Tomita N., Takesue Y. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease. Dis Colon Rectum 2013 Oct, 56(10):1156-1165.
33. Yang Z.P., Hong L., Wu Q., Wu K.C., Fan D.M. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis. Int J Surg 2014, 12(3):224-230.
34. Kasparek M.S., Bruckmeier A., Beigel F., Muller M.H., Brand S., Mansmann U., et al. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. Inflamm Bowel Dis 2012, 18:1207-1213.
35. Myrelid P., Marti-Gallostra M., Ashraf S., Sunde M.L., Tholin M., Oresland T., Lovegrove R.E., Tøttrup A., Kjaer D.W., George B.D. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy. Br J Surg 2014 Apr, 101(5):539-545.
36. Nelson R., Liao C., Fichera A., Rubin D.T., Pekow J. Rescue therapy with cyclosporine or infliximab is not associated with an increased risk for postoperative complications in patients hospitalized for severe steroid-refractory ulcerative colitis. Inflamm Bowel Dis 2014, 20:14-20.
37. Schaufler C., Lerer T., Campbell B., Weiss R., Cohen J., Sayej W., et al. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis. J Pediatr Gastroenterol Nutr 2012, 55:421-424.
38. Kaplan G.G., McCarthy E.P., Ayanian J.Z., Korzenik J., Hodin R., Sands B.E. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology 2008, 134:680-687.
39. Bitton A., Buie D., Enns R., Feagan B.G., Jones J.L., Marshall J.K., et al. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol 2012, 107:179-194.